title: Letter: clarithromycin dose for H. pylori therapy remains unresolved.
authors.affiliation: Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, TX, USA. dgraham@bcm.edu.
authors.forename: D Y
authors.initials: DY
authors.lastname: Graham
authors.affiliation: Gastroenterology Unit, Hospital Universitario de La Princesa, IIS-IP and CIBEREHD, Madrid, Spain.
authors.forename: J P
authors.identifier: http://orcid.org/0000-0003-2090-3445
authors.initials: JP
authors.lastname: Gisbert
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017291:Clarithromycin / Q000627:therapeutic use*; D016481:Helicobacter Infections / Q000188:drug therapy*; D006801:Humans
chemical_list: D000900:Anti-Bacterial Agents; D017291:Clarithromycin